Results
|
|
1841.
|
|
|
|
1842.
|
|
|
|
1843.
|
|
|
|
1844.
|
|
|
|
1845.
|
|
|
|
1846.
|
|
|
|
1847.
|
|
|
|
1848.
|
|
|
|
1849.
|
Characterization of tumor mutation burden, PD-L1 and DNA repair genes to assess relationship to immune checkpoint inhibitors response in metastatic renal cell carcinoma. [electronic resource] by
- Labriola, Matthew Kyle
- Zhu, Jason
- Gupta, Rajan T
- McCall, Shannon
- Jackson, Jennifer
- Kong, Eric F
- White, James R
- Cerqueira, Gustavo
- Gerding, Kelly
- Simmons, John K
- George, Daniel
- Zhang, Tian
Producer: 20210819
In:
Journal for immunotherapy of cancer vol. 8
Availability: No items available.
|
|
|
1850.
|
Programmed Cell Death Ligand Expression Drives Immune Tolerogenesis across the Diverse Subtypes of Neuroendocrine Tumours. [electronic resource] by
- Pinato, David J
- Vallipuram, Anu
- Evans, Joanne S
- Wong, Clement
- Zhang, Hua
- Brown, Matthew
- Dina, Roberto E
- Trivedi, Pritesh
- Akarca, Ayse U
- Marafioti, Teresa
- Mauri, Francesco A
- Sharma, Rohini
Producer: 20211117
In:
Neuroendocrinology vol. 111
Availability: No items available.
|
|
|
1851.
|
Costimulatory molecule B7-H1 in primary and metastatic clear cell renal cell carcinoma. [electronic resource] by
- Thompson, R Houston
- Gillett, Michael D
- Cheville, John C
- Lohse, Christine M
- Dong, Haidong
- Webster, W Scott
- Chen, Lieping
- Zincke, Horst
- Blute, Michael L
- Leibovich, Bradley C
- Kwon, Eugene D
Producer: 20060110
In:
Cancer vol. 104
Availability: No items available.
|
|
|
1852.
|
|
|
|
1853.
|
|
|
|
1854.
|
Renal tubular PD-L1 (CD274) suppresses alloreactive human T-cell responses. [electronic resource] by
- Starke, Astrid
- Lindenmeyer, Maja T
- Segerer, Stephan
- Neusser, Matthias A
- Rüsi, Barbara
- Schmid, Daniel M
- Cohen, Clemens D
- Wüthrich, Rudolf P
- Fehr, Thomas
- Waeckerle-Men, Ying
Producer: 20100922
In:
Kidney international vol. 78
Availability: No items available.
|
|
|
1855.
|
|
|
|
1856.
|
MPDL3280A (anti-PD-L1) treatment leads to clinical activity in metastatic bladder cancer. [electronic resource] by
- Powles, Thomas
- Eder, Joseph Paul
- Fine, Gregg D
- Braiteh, Fadi S
- Loriot, Yohann
- Cruz, Cristina
- Bellmunt, Joaquim
- Burris, Howard A
- Petrylak, Daniel P
- Teng, Siew-leng
- Shen, Xiaodong
- Boyd, Zachary
- Hegde, Priti S
- Chen, Daniel S
- Vogelzang, Nicholas J
Producer: 20150219
In:
Nature vol. 515
Availability: No items available.
|
|
|
1857.
|
|
|
|
1858.
|
PD-L1 expression in the Merkel cell carcinoma microenvironment: association with inflammation, Merkel cell polyomavirus and overall survival. [electronic resource] by
- Lipson, Evan J
- Vincent, Jeremy G
- Loyo, Myriam
- Kagohara, Luciane T
- Luber, Brandon S
- Wang, Hao
- Xu, Haiying
- Nayar, Suresh K
- Wang, Timothy S
- Sidransky, David
- Anders, Robert A
- Topalian, Suzanne L
- Taube, Janis M
Producer: 20150204
In:
Cancer immunology research vol. 1
Availability: No items available.
|
|
|
1859.
|
Blockade of the programmed death-1 (PD1) pathway undermines potent genetic protection from type 1 diabetes. [electronic resource] by
- Kochupurakkal, Nora M
- Kruger, Annie J
- Tripathi, Sudipta
- Zhu, Bing
- Adams, La Tonya
- Rainbow, Daniel B
- Rossini, Aldo
- Greiner, Dale L
- Sayegh, Mohamed H
- Wicker, Linda S
- Guleria, Indira
Producer: 20141104
In:
PloS one vol. 9
Availability: No items available.
|
|
|
1860.
|
A STING Agonist Given with OX40 Receptor and PD-L1 Modulators Primes Immunity and Reduces Tumor Growth in Tolerized Mice. [electronic resource] by
- Foote, Jeremy B
- Kok, Marleen
- Leatherman, James M
- Armstrong, Todd D
- Marcinkowski, Bridget C
- Ojalvo, Laureen S
- Kanne, David B
- Jaffee, Elizabeth M
- Dubensky, Thomas W
- Emens, Leisha A
Producer: 20180308
In:
Cancer immunology research vol. 5
Availability: No items available.
|